![](/img/cover-not-exists.png)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Geletneky, Karsten, Hajda, Jacek, Angelova, Assia L., Leuchs, Barbara, Capper, David, Bartsch, Andreas J., Neumann, Jan-Oliver, Schöning, Tilman, Hüsing, Johannes, Beelte, Birgit, Kiprianova, Irina, RLanguage:
english
Journal:
Molecular Therapy
DOI:
10.1016/j.ymthe.2017.08.016
Date:
August, 2017
File:
PDF, 2.05 MB
english, 2017